Anthony P. Adamis serves as Executive at EyePoint Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Anthony P. Adamis has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 23, 2024 involved exercising options for 2,000 shares valued at $0.
Anthony P. Adamis currently holds 4,000 shares of EyePoint Pharmaceuticals, Inc. (EYPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony P. Adamis has been a net neutral trader of EYPT stock. They have purchased $0 and sold $0 worth of shares.
Anthony P. Adamis's most recent insider trade was on Jun 23, 2024, when they sold 2,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,000 |
| $N/A |
| Discretionary |